Results 231 to 240 of about 165,346 (280)

Therapeutic strategies to target the Ebola virus life cycle

Nature Reviews Microbiology, 2019
T. Hoenen, A. Groseth, H. Feldmann
semanticscholar   +1 more source

Ebola Stigma and Its Impact on Outbreak Control: Lessons From Key Informant Interviews in Central Uganda. [PDF]

Trop Med Int Health
Paterson A, Kabajaasi O, Adlard F, Dimitrios KH, Cheyne A, Ssewankambo Y, Kaggwa D, Olliaro P, Kenya-Mugisha N, Rojek A.   +9 more
europepmc   +1 more source

Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV

Nature Medicine, 2019
S. Ehrhardt, Matthias Zehner, Verena Krähling, H. Cohen-Dvashi, Christoph Kreer, N. Elad, H. Gruell, M. Ercanoglu, P. Schommers, L. Gieselmann, R. Eggeling, C. Dahlke, T. Wolf, N. Pfeifer, M. Addo, R. Diskin, S. Becker, F. Klein   +17 more
semanticscholar   +1 more source

Forecasting the spatial spread of an Ebola epidemic in real time: Comparing predictions of mathematical models and experts. [PDF]

Elife
Munday JD, Rosello A, Edmunds WJ, Funk S.   +3 more
europepmc   +1 more source

Evidence of resiliency in maternal health services and outcomes in Kono District, Sierra Leone during the COVID-19 pandemic: an observational study. [PDF]

BMC Public Health
Boima F, Mekonnen ZA, Koroma MM, Lado M, Chan AK, Mishra S, N'jai AU, Molleh B, Sevalie S, Lakoh S.   +9 more
europepmc   +1 more source

Viral zoonotic disease outbreaks and response strategies in Sub-Saharan Africa: a scoping review. [PDF]

One Health Outlook
Aryeetey S, El-Duah P, Gmanyami JM, Agyei G, Sylverken AA, Dumevi RM, Tasiame W, Adu-Sarkodie Y, Phillips RO, Drosten C, Owusu M.   +10 more
europepmc   +1 more source

Post-exposure prevention in Marburg virus outbreaks: potential role of remdesivir in emergency response. [PDF]

Ann Med Surg (Lond)
Tague C, Ekouo J, Makeda D, Yokolo H, Onesime J, Banga S, Kashafali A, Akilimali A.   +7 more
europepmc   +1 more source

Title: Short-term health system responses to epidemics across hard-to-reach areas in sub-Saharan Africa: A scoping review

Murunga AA, Ngoye B, Wafula FP.
europepmc   +1 more source

Safety and immunogenicity of rVSVΔG-ZEBOV-GP vaccination when dosed concurrent with mRNA COVID-19 vaccine booster doses in healthy African adults (EbolaCov): protocol for a phase IV, single-centre, single-blinded, randomised controlled trial. [PDF]

BMJ Open
Gokani K, Taylor A, Packham A, Musabyimana JP, Shema H, Mutabaruka A, Roche S, Takwoingi Y, Umuhoza C, Nyombayire J, Muvunyi C, Green C.   +11 more
europepmc   +1 more source

Vector-Induced Humoral Responses After rVSVΔG-ZEBOV-GP Immunization Identify Vaccinated Individuals and Correlate With Ebola Virus Glycoprotein Antibodies. [PDF]

J Infect Dis
Chandrasekaran P, Berry IM, Callier V, Anthony SM, Hensley K, Kuhn JH, Shaw-Saliba K, Kennedy SB, Kieh M, Browne SM, Crozier I, Davey RT, Lane HC, Hensley LE, Follmann DA.   +14 more
europepmc   +1 more source